BAM
SGMO

Blueshift Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Blueshift Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,375
Closed -$130K – 1184
2021
Q3 		$130K Sell
14,375
-16,025
-53% -$158K 0.01% 950
2021
Q2 		$364K Buy
+30,400
New +$344K 0.02% 662
2021
Q1 		– Sell
-29,029
Closed -$453K – 1051
2020
Q4 		$453K Buy
29,029
+4,551
+19% +$53.3K 0.05% 431
2020
Q3 		$231K Buy
+24,478
New +$265K 0.03% 518

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blueshift Asset Management's SGMO Position: Q4 2021 in Review

Blueshift Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 14,375 shares — an estimated $130K sold.

Blueshift Asset Management first reported a position in SGMO in Q3 2020 and held it in 4 quarters. The position peaked at $453K in Q4 2020. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • Blueshift Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 14,375 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $130K.
  • Blueshift Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and held it in 4 quarters.
  • Blueshift Asset Management's SANGAMO THERAPEUTICS INC position peaked at $453K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.